VEGFA and cancer: More specifically, addition of anti-VEGF antibody therapy to standard chemotherapies has improved survival and is an accepted standard of care for a number of cancer types such as cervical cancer (90), colorectal cancer, prostate cancer (91), and advanced non-small cell lung cancer (92).